Amino acid control of muscle protein turnover in renal disease

被引:5
|
作者
Ferrando, AA
Raj, D
Wolfe, RR
机构
[1] Univ Texas, Med Branch, Dept Surg, Galveston, TX 77550 USA
[2] Univ New Mexico, Albuquerque, NM 87131 USA
关键词
D O I
10.1053/j.jrn.2004.09.014
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
This review discusses the concept that skeletal muscle intracellular amino acids (ICAAs), in particular the essential amino acids, are regulated throughout a wide range of physiologic circumstances. Whether in critical illness, severe injury, or healthy states, ICAAs are closely regulated by a coordinated response in 1 or more of the processes of synthesis, breakdown, and tissue transport. For a given metabolic signal (hormonal, change in plasma amino acid concentrations), the regulation of ICAAs entails appropriate and corresponding changes in amino acid kinetics. These changes vary according to the strength of the metabolic signal and the existing requirement to maintain the ICAA pool. For the patient with end-stage renal disease (ESRD), frequent dialysis induces an abrupt removal of half of the circulating amino acids, which in turn results in a substantial efflux of amino acids from skeletal muscle. ICAAs are maintained through the increase in protein breakdown, and similar to other stress states, there is a concomitant increase in protein synthesis. Thus, the regulation of ICAAs often pushes subsequent adaptations in amino acid kinetics to maintain the existing homeostasis. This regulatory mechanism is evident in circumstances ranging from increased amino acid availability in healthy volunteers to a change in anabolic signal in severe injury. Despite the substantial evidence of ICAA regulation, its physiologic significance is not evident. However, the regulation of ICAAs represents a method by which skeletal muscle ensures its capacity for anabolism. (C) 2005 by the National Kidney Foundation, Inc.
引用
收藏
页码:34 / 38
页数:5
相关论文
共 50 条
  • [41] MUSCLE PROTEIN-TURNOVER AND THE WASTING DUE TO INJURY AND DISEASE
    RENNIE, MJ
    BRITISH MEDICAL BULLETIN, 1985, 41 (03) : 257 - 264
  • [42] Influence of Amino Acids and Exercise on Muscle Protein Turnover, Particularly in Cancer Cachexia
    Pradhan, Rashmita
    Dieterich, Walburga
    Natarajan, Anirudh
    Schwappacher, Raphaela
    Reljic, Dejan
    Herrmann, Hans J.
    Neurath, Markus F.
    Zopf, Yurdaguel
    CANCERS, 2024, 16 (10)
  • [43] CURRENT CONCEPTS OF PROTEIN-TURNOVER AND AMINO-ACID TRANSPORT IN LIVER AND SKELETAL-MUSCLE DURING SEPSIS
    HASSELGREN, PO
    PEDERSEN, P
    SAX, HC
    WARNER, BW
    FISCHER, JE
    ARCHIVES OF SURGERY, 1988, 123 (08) : 992 - 999
  • [44] Increased amino acid turnover and myofibrillar protein breakdown in advanced cancer are associated with muscle weakness and impaired physical function
    van der Meij, Barbara S.
    Deutz, Nicolaas E. P.
    Rodriguez, Ramon E. R.
    Engelen, MarieIle P. K. J.
    CLINICAL NUTRITION, 2019, 38 (05) : 2399 - 2407
  • [45] Protein turnover in pregnant pigs at amino acid intake in excess of requirements
    Moehn, Soenke
    Rafii, Mahroukh
    Pencharz, Paul B.
    Ball, Ronald O.
    FASEB JOURNAL, 2013, 27
  • [46] Protein turnover, amino acid requirements and recommendations for athletes and active populations
    Poortmans, J. R.
    Carpentier, A.
    Pereira-Lancha, L. O.
    Lancha, A., Jr.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2012, 45 (10) : 875 - 890
  • [47] EFFECT OF AMINO-ACID REUTILIZATION IN DETERMINATION OF PROTEIN TURNOVER IN MICE
    ALEMANY, M
    HORMONE AND METABOLIC RESEARCH, 1976, 8 (01) : 70 - 73
  • [48] PROTEIN TURNOVER IN AMINO ACID-STARVED STRAINS OF ESCHERICHIA COLI K-12 DIFFERING IN THEIR RIBONUCLEIC ACID CONTROL
    SUSSMAN, AJ
    GILVARG, C
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1969, 244 (22) : 6304 - +
  • [49] Amino acid availability controls muscle protein metabolism
    Wolfe, RR
    Miller, SL
    DIABETES NUTRITION & METABOLISM, 1999, 12 (05) : 322 - 328
  • [50] Muscle Protein Hydrolysates and Amino Acid Composition in Fish
    Ryu, Bomi
    Shin, Kyung-Hoon
    Kim, Se-Kwon
    MARINE DRUGS, 2021, 19 (07)